United Therapeutics (UTHR) Invested Capital (2017 - 2025)
United Therapeutics (UTHR) posted Invested Capital of $200.0 million for Q1 2025, down 33.33% sequentially from $300.0 million in Q4 2024, and down 50.0% YoY from $400.0 million in Q1 2024.
United Therapeutics (UTHR) Invested Capital (2017 - 2025) Analysis & Trends
United Therapeutics has reported Invested Capital for 6 years, with the latest figure at $200.0 million in Q1 2025.
- Quarterly Invested Capital fell 50.0% year-over-year to $200.0 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $200.0 million (down 86.67% YoY) and the FY2024 annual result came in at $300.0 million, down 25.0% from the prior year.
- Invested Capital declined to $200.0 million in Q1 2025 per UTHR's latest filing, from $300.0 million in the prior quarter.
- Over five years, Invested Capital peaked at $400.0 million in Q4 2023 and troughed at $200.0 million in Q1 2025.
- A 3-year average of $342.9 million and a median of $400.0 million in 2023 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2024 and 2025: Invested Capital soared 33.33% in 2024, then plunged 50.0% in 2025.
- Over 3 years, Invested Capital stood at $400.0 million in 2023, then retreated by 25.0% to $300.0 million in 2024, then plunged by 33.33% to $200.0 million in 2025.
- According to Business Quant data, Invested Capital over the past three periods registered $200.0 million, $300.0 million, and $400.0 million for Q1 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 630.00 Mn |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | 26.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 200.00 Mn |
| Dec 31, 2024 | 300.00 Mn |
| Sep 30, 2024 | 400.00 Mn |
| Jun 30, 2024 | 400.00 Mn |
| Mar 31, 2024 | 400.00 Mn |
| Dec 31, 2023 | 400.00 Mn |
| Sep 30, 2023 | 300.00 Mn |
| Dec 31, 2019 | 250.00 Mn |
| Sep 30, 2019 | 250.00 Mn |
| Jun 30, 2019 | 250.00 Mn |
| Dec 31, 2018 | 250.00 Mn |
| Dec 31, 2017 | 250.00 Mn |
| Sep 30, 2017 | 250.00 Mn |
| Jun 30, 2017 | 250.00 Mn |